Protease activated receptor 4 (PAR4) antagonists: Research progress on small molecules in the field of antiplatelet agents

被引：15
|
作者：
Liu, Shangde [1 ]
Li, Shanshan [1 ]
Yuan, Duo [1 ]
Wang, Enmao [1 ]
Xie, Roujie [1 ]
Zhang, Weiqi [1 ]
Kong, Yi [2 ]
Zhu, Xiong [1 ]
机构：
[1] China Pharmaceut Univ, Inst Med & Chem, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Sch Life & Technol, Nanjing 210009, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 209卷
关键词：
PAR4; Small-molecule antagonists; Antiplatelet agents; SAR; Structural optimization; BMS-986120; BMS-986141; Preclinical trials; Clinical trials; ACUTE CORONARY SYNDROMES; THROMBIN-RECEPTOR; PLATELET ACTIVATION; THROMBOXANE PRODUCTION; IN-VITRO; INHIBITION; YD-3; AGGREGATION; DISCOVERY; PEPTIDES;
D O I：
10.1016/j.ejmech.2020.112893
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Protease activated receptor 4 (PAR4) is a key target in antiplatelet medication to reduce the risk of heart attack and thrombotic complications in stroke. PAR4 antagonists can prevent harmful and stable thrombus growth while retaining initial thrombus formation by acting on the late diffusion stage of platelet activation, which may provide a safer alternative than other antiplatelet agents. Currently, research on PAR4 antagonists is of increasing interest in the field of antiplatelet agents. This article provides an overview of the discovery and development of small-molecule antagonists of PAR4 as novel antiplatelet agents, including structure-activity relationship (SAR) analysis, progress of structure and bioassay optimization, and the latest structural and/or clinical information of representative small-molecule antagonists of PAR4. (c) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：15
相关论文
共 50 条
  • [31] Complement factor C4a does not activate protease-activated receptor 1 (PAR1) or PAR4 on human platelets
    Han, Xu
    de la Fuente, Maria
    Nieman, Marvin T.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (01) : 104 - 110
  • [32] Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions
    Bilodeau, Matthew L.
    Hamm, Heidi E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (02): : 778 - 788
  • [33] Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets
    Duvernay, Matthew
    Young, Summer
    Gailani, David
    Schoenecker, Jonathan
    Hamm, Heidi
    MOLECULAR PHARMACOLOGY, 2013, 83 (04) : 781 - 792
  • [34] PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
    Wilson, Simon J.
    Ismat, Fraz A.
    Wang, Zhaoqing
    Cerra, Michael
    Narayan, Hafid
    Raftis, Jennifer
    Gray, Timothy J.
    Connell, Shea
    Garonzik, Samira
    Ma, Xuewen
    Yang, Jing
    Newby, David E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (02) : 448 - 456
  • [35] Protease-Activated Receptor 4 (PAR4) Plays a Critical Role in Fetal Loss and Peripheral Thrombosis in a Mouse Model of Thrombophilia
    Siner, Joshua
    Freguia, Christian Furlan
    Maiden, Michael
    Liu, Jianhua
    Baila, Stefano
    Arruda, Valder
    BLOOD, 2011, 118 (21) : 173 - 173
  • [36] Calcium Mobilization And Protein Kinase C Activation Downstream Of Protease Activated Receptor 4 (PAR4) Is Negatively Regulated By PAR3 In Mouse Platelets
    Arachiche, Amal
    de la Fuente, Maria
    Nieman, Marvin T.
    PLOS ONE, 2013, 8 (02):
  • [37] Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets
    Falker, Knut
    Haglund, Linda
    Gunnarsson, Peter
    Nylander, Martina
    Lindahl, Tomas L.
    Grenegard, Magnus
    BIOCHEMICAL JOURNAL, 2011, 436 : 469 - 480
  • [38] Inhibition of protease-activated receptor 4 (PAR4) suppresses C4a-induced invasion of lung cancer cells in vitro.
    Wang, Hongbin
    Xiong, Lingxin
    Wang, Zhibin
    Wang, Yuanyuan
    Xu, Ling
    Zhang, Weidong
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 37 - 38
  • [39] Novel Role for Proteinase-activated Receptor 2 (PAR2) in Membrane Trafficking of Proteinase-activated Receptor 4 (PAR4)
    Cunningham, Margaret R.
    McIntosh, Kathryn A.
    Pediani, John D.
    Robben, Joris
    Cooke, Alexandra E.
    Nilsson, Mary
    Gould, Gwyn W.
    Mundell, Stuart
    Milligan, Graeme
    Plevin, Robin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (20) : 16656 - 16669
  • [40] Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter
    Huang, Shih-Che
    REGULATORY PEPTIDES, 2007, 142 (1-2) : 37 - 43
12345